Effect of tolvaptan on acute heart failure with hyponatremia – A randomized, double blind, controlled clinical trial

Effect of tolvaptan on acute heart failure with hyponatremia – A randomized, double blind, controlled clinical trial

Objectives: To assess the efficacy of tolvaptan in acute heart failure with hyponatremia using a randomized double-blinded placebo-controlled study design. Background: Tolvaptan is a selective vasopressin receptor 2 antagonist. There are no published clinical trials on the utility of tolvaptan in ac...

Full description

Bibliographic Details
Main Authors: Elangovan Shanmugam, C.R. Madhu Prabhu Doss, Melvin George, Amrita Jena, Muthukumar Rajaram, Balaji Ramaraj, Karthik Anjaneyan, B. Kanagesh
Format: Article
Language:English
Published: Elsevier 2016-04-01
Series:Indian Heart Journal
Subjects:
Tolvaptan
Heart failure
Hyponatremia
Dyspnea
Randomized clinical trial
Online Access:http://www.sciencedirect.com/science/article/pii/S0019483215002394

Internet

http://www.sciencedirect.com/science/article/pii/S0019483215002394

Similar Items